Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Severe septal panniculitis in a multiple sclerosis patient treated with interferon-beta.
[Chronically Ill and Unemployed? A Review on Vocational Status in Multiple Sclerosis].
Gammaherpesvirus Infection of Human Neuronal Cells.
Increasing age at disability milestones among MS patients in the MSBase Registry.
1st International Symposium on Gait and Balance in MS: Gait and Balance Measures in the Evaluation of People with MS.
Interferon Beta-1a (AVONEX®) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study.
Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation.
Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases.
Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS.
ATP increases the migration of microglia across the brain endothelial cell monolayer.
Multiple sclerosis shrinks intralesional, and enlarges extralesional, brain parenchymal veins.
Navigating Life and Loss in Pediatric Multiple Sclerosis.
The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study.
Perceived impact of spasticity is associated with spatial and temporal parameters of gait in multiple sclerosis.
Daughters of mothers with multiple sclerosis: their experiences of play.
[Application of laser therapy in the physiotherapy of patients with multiple sclerosis].
Recommendations for the management of multiple sclerosis relapses.
Characteristics of persons with overactive bladder of presumed neurologic origin: Results from the boston area community health (BACH) survey.
Macrophage and NK-mediated killing of precursor-B acute lymphoblastic leukemia cells targeted with a-fucosylated anti-CD19 humanized antibodies.
Riluzole increases glutamate uptake by cultured C6 astroglial cells.
Center for Drug Evaluation and Research Approval Letter, application number: 21-897
The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system?
Lysoglycerophospholipids in chronic inflammatory disorders: The PLA(2)/LPC and ATX/LPA axes.
Aging, widowhood, multiple sclerosis, and a dog.
Sexual Behavior, Body Image, and Partnership in Chronic Illness: A Comparison of Huntington's Disease and Multiple Sclerosis.
Pages
« first
‹ previous
…
196
197
198
199
200
201
202
203
204
…
next ›
last »